SCHEMBL2315971

SCHEMBL2315971

CC(=O)C=CC1=CC(C)(C)COc2ccc(Cl)cc21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 2/20 0.35
IDO1 P14902 1/20 0.34
TDO2 P48775 1/20 0.34
TGM2 P21980 1/20 0.34
NOTUM Q6P988 1/20 0.34
MAOB P27338 3/20 0.34
MGAT2 Q10469 1/20 0.34
NPC1 O15118 4/20 0.33
MAPT P10636 3/20 0.33
RAB9A P51151 3/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
TRPV1 Q8NER1 2/20 0.33
PGR P06401 1/20 0.33
THRB P10828 1/20 0.33
HTT P42858 1/20 0.33
CASP3 P42574 1/20 0.33
SENP7 Q9BQF6 1/20 0.33
RARA P10276 2/20 0.33
RARB P10826 2/20 0.33
RARG P13631 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2315966 1.00 AR (0.35) ARIDO1TDO2TGM2NOTUM
SCHEMBL2317450 0.90 MAPK1 (0.33) ARIDO1TDO2TGM2MAOB
SCHEMBL2317453 0.90 MAPK1 (0.33) ARIDO1TDO2TGM2MAOB
SCHEMBL3607982 0.88 RXRA (0.45) ARNOTUMMAPTHTTRARA
SCHEMBL3607980 0.88 RXRA (0.45) ARNOTUMMAPTHTTRARA
SCHEMBL2315354 0.86 MAPT (0.35) MAOBNPC1MAPTRAB9ASMN1; SMN2
SCHEMBL2315349 0.86 MAPT (0.35) MAOBNPC1MAPTRAB9ASMN1; SMN2
SCHEMBL2314394 0.85 APP (0.34) ARMAOBMAPTSMN1; SMN2PGR
SCHEMBL2316995 0.85 ALDH1A1 (0.39) ARTGM2NOTUMMAOBMAPT
SCHEMBL2316992 0.85 ALDH1A1 (0.39) ARTGM2NOTUMMAOBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1609786-B1 5-alkenone-3,3-dimethyl-benzoxepines derivatives useful for the preparation of antidiabetic pentadienoic acids MERCK SANTE SAS (FR) 2011-08-03 EP claimed
EP-1758876-A1 NEW 5-ALKENONE-3,3-DIMETHYL-BENZOXEPINES DERIVATIVES USEFUL FOR THE PREPARATION OF ANTIDIABETIC PENTADIENOIC ACIDS MERCK PATENT GmbH (DE) 2007-03-07 EP claimed
WO-2006002721-A1 NEW 5-ALKENONE-3,3-DIMETHYL-BENZOXEPINES DERIVATIVES USEFUL FOR THE PREPARATION OF ANTIDIABETIC PENTADIENOIC ACIDS MERCK PATENT GMBH (DE) 2006-01-12 WO claimed
EP-1609786-A1 New 5-alkenone-3,3-dimethyl-benzoxepines derivatives useful for the preparation of antidiabetic pentadienoic acids Merck Sante (FR) 2005-12-28 EP claimed
EP-1609786-B1 5-alkenone-3,3-dimethyl-benzoxepines derivatives useful for the preparation of antidiabetic pentadienoic acids MERCK SANTE SAS (FR) 2011-08-03 EP disclosed
EP-1758876-A1 NEW 5-ALKENONE-3,3-DIMETHYL-BENZOXEPINES DERIVATIVES USEFUL FOR THE PREPARATION OF ANTIDIABETIC PENTADIENOIC ACIDS MERCK PATENT GmbH (DE) 2007-03-07 EP disclosed
WO-2006002721-A1 NEW 5-ALKENONE-3,3-DIMETHYL-BENZOXEPINES DERIVATIVES USEFUL FOR THE PREPARATION OF ANTIDIABETIC PENTADIENOIC ACIDS MERCK PATENT GMBH (DE) 2006-01-12 WO disclosed
EP-1609786-A1 New 5-alkenone-3,3-dimethyl-benzoxepines derivatives useful for the preparation of antidiabetic pentadienoic acids Merck Sante (FR) 2005-12-28 EP disclosed